Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05503862 · ClinicalTrials.gov registry record · NA
Home Semen Testing in Men Beginning Attempts to Conceive
A NA study of Male Infertility, sponsored by Northwestern University.
- Active
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05503862: Active NA study of Male Infertility, sponsored by Northwestern University.
NCT05503862 is a NA study of Male Infertility that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 200 participants, below the 533-participant average among 8 other Male Infertility trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05503862, a NA study of Male Infertility, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective of the proposed study is to enhance early detection of male factor infertility and reduce cost and morbidity associated with delayed diagnosis through development of a universal screening model based on home semen testing. The advent of inexpensive and accurate home semen testing has enabled a potential paradigm shift in the approach to male fertility evaluation. The investigator's central hypothesis is that universal home semen testing prior to attempts to conceive is easy for participants and can lead to reduced fertility-related anxiety and early detection of male factor infertility, thereby expediting evaluation and treatment for the couple while minimizing unnecessary cost and morbidity. This study is specifically designed to assess the feasibility and utility of home semen testing for couples who are beginning attempts to conceive. First, the investigator will assess participants' ability to complete the home semen testing, ease of use, and obstacles encountered in doing so. Second, the investigator will examine the impact of home semen testing in fertility-related quality of life among couples beginning attempts to conceive, as well as ability of home semen testing to increase the diagnosis and treatment of male infertility in these couples.
Primary Outcome
To assess if participants randomized to the home semen testing utilize the YoSperm device to complete the home semen testing.
Conditions Studied
Interventions
- DEVICE YoSperm
Study Locations (1)
Illinois
- Northwestern University Department of Urology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-09-09 |
| Est. Completion | 2025-10 |
| Phase | NA |
What the registry record for NCT05503862 still lists
NCT05503862 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 533-participant average among 8 other Male Infertility trials with a reported enrollment target (62% lower).
The record links to 1 condition, with Male Infertility appearing as the primary indexed condition, and to 1 intervention - of which YoSperm is the first listed.
NCT05503862 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05503862 about?
NCT05503862 is a clinical study titled "Home Semen Testing in Men Beginning Attempts to Conceive". The overall objective of the proposed study is to enhance early detection of male factor infertility and reduce cost and morbidity associated with delayed diagnosis through development of a universal screening model based on home semen testing. The advent of inexpensive and accurate home semen testi...
What is the current status of trial NCT05503862?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2022-09-09. Estimated completion is 2025-10.
What conditions does trial NCT05503862 study?
This clinical trial studies the following conditions: Male Infertility.
What interventions are being tested in trial NCT05503862?
The interventions under investigation include: YoSperm (DEVICE).
Who is sponsoring clinical trial NCT05503862?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05503862 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Male Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05503862's enrollment target sits among peer trials
200 5th of 8 higher than 4 of 8 other Male Infertility trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Male Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Platelet Rich Plasma Testis Treatment for Infertile Men
RECRUITING · NA
-
To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That Develop to the Point That They Are Able to be Transferred) in IVF Cycles.
ACTIVE NOT RECRUITING · NA
-
Male Infertility and Assisted Reproductive Technologies Research Biobank
RECRUITING
-
SpermQT Prospective Observational Trial
ACTIVE NOT RECRUITING
-
A Pilot Study to Evaluate the Effect of Pomegranate Juice on Semen Parameters in Healthy Male Volunteers
COMPLETED · Phase 1
-
Small RNA Pathways in Mammalian Gametogenesis
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI